Co-Diagnostics, Inc. CFO Departs; New Principal Financial Officer Appointed

What Happened
Co-Diagnostics, Inc. filed an 8-K reporting that Chief Financial Officer Brian Brown’s last day was September 2, 2026. Effective that date, Daniel Bohrer, the Company’s Executive Vice President of Finance and Accounting, was designated as the Company’s principal financial officer and principal accounting officer. In connection with the appointment, Mr. Bohrer’s annual salary was increased from $225,000 to $255,000.

Key Details

• Separation date: Brian Brown’s employment ended September 2, 2026.
• New principal financial/accounting officer: Daniel Bohrer, age 49, effective September 2, 2026.
• Compensation change: Bohrer’s annual salary raised from $225,000 to $255,000.
• Background and independence: Bohrer served as VP of Finance & Accounting from Sept 2021–Sept 2026, became EVP of Finance & Accounting in Sept 2026, previously held accounting roles at Workfront and EY, holds an MBA and BS in Accounting, is a licensed CPA in Utah, and has no family or related‑party transactions with the company.

Why It Matters
This filing updates who is responsible for the company’s financial reporting and SEC filings (principal financial officer and principal accounting officer). The appointment is an internal promotion with a modest salary increase and highlights continuity in finance leadership; investors should note the executive change as it relates to ongoing financial oversight and communications with auditors and regulators.